Deep Science Ventures

Do you have the drive to reverse fibrosis? 👇 🕵♀️ We're seeking a CEO / Commercial Founder in Residence to lead a groundbreaking new venture combatting fibrosis. This is an opportunity to be at the cutting edge of fibrosis drug development. You'll drive innovation in immune resolution and myeloid reprogramming, building a company designed to solve critical unmet needs. ✅ We've partnered with General Inception to bring this to life and accelerate the development of novel therapeutics, jointly building a new venture solely dedicated to anti-fibrotic therapies. 💡 Who's perfect for this role? If you're a seasoned biotech leader with a strong track record in early stage therapeutics and successful VC fundraising - we'd love to meet you! Ready to build a future free from fibrosis? Application link in the comments!

What if one of the biggest threats to our health and planet is invisible, yet found in our air, food, and water? Excited to share a preview of our latest report - "The Invisible Tsunami," created by our team and funded by The Grantham Foundation for the Protection of the Environment. Over eight months, we conducted an extensive analysis, including 50+ interviews with global experts and countless peer-reviewed studies. This research shows that the impacts of chemical toxicity are largely underestimated, contributing to increasing cancer rates, declining fertility, and a surge in chronic diseases, alongside ecosystem damage. Consider these facts: - Over 3,600 synthetic chemicals from food contact materials are found within human bodies globally. - PFAS have contaminated across the globe, with levels in rainwater often exceeding safe drinking water limits. - Over 90% of the global population is exposed to air pollution exceeding World Health Organisation (WHO) guidelines. - The impact of pesticide use on cancer incidence may rival that of smoking and is linked to leukaemia, non-Hodgkin’s lymphoma, bladder, colon, and liver cancer. Prenatal pesticide exposure increases the odds of childhood leukemia and lymphoma by over 50%. But this report isn't just about the problem; it's a call to action for solutions. We highlight critical industry, regulatory gaps and, most importantly, identify key areas for innovation and urgent funding that can put us on the right path to increase our understanding and make positive changes where it's most needed. You can read the executive summary below and listen to Harry Macpherson, our Senior Associate, Climate speak with the The Foundation For Science and Technology, link in comments! Stay tuned for the full report in the upcoming weeks! cc Adam Tomassi-Russell Noah Geeves Maki Tazawa Josh Agenbroad Pina Fritz, PhD Kevin Tidwell

Dr. Thane Campbell recently caught up with Sofia Chesnokova at Tech Funding News ! In light of the recent report by Dealroom.co, which highlights Switzerland as setting a remarkable standard for deep tech innovation in Europe, a model for others to emulate, they talked about the current state of deep tech across Europe, drawing comparisons with Switzerland. Thane eloquently articulated the "two-fold" gap we face in the UK: "The gap is two-fold: translation gap going from academia into entrepreneurship and funding gap. Based on our calculations, we require 50 times more funding for deep tech to achieve the UK's policy and economic goals. While research councils fund research and studentships, and Innovate UK backs innovation, there’s no dedicated person, team, funding pot, or organisation within the UK government or its agencies focused on venture creation itself. This ‘no-man’s land’ overlooks a vital reality that very often deep tech startup creation happens off campus.” Having witnessed the success of the deep tech companies we've created over the last decade, we’re excited about the future potential of deep tech in the UK. By addressing these critical gaps, we can unlock incredible growth. Read the full article: https://lnkd.in/d5efEWk5

Fresh off London Climate Action Week, Noah Geeves, our Head of Portfolio and Partnerships, chatted with Martin SFP Bryant from PreSeed Now. They dove into how we've successfully built 50+ ventures in 8 years, combining available scientific knowledge and founder-type scientists into high-impact ventures. Some things they discussed: - Despite recent market shifts, it's a great time to be a climate tech founder. Committed investors, corporate net-zero goals, and a higher bar for innovation mean this is still fertile ground. - Europe is leading the charge in global climate progress, with strong support for startups across deployment stages. - Based on experience spanning 10+ years, Noah shared practical advice on how climate focused startups can prepare themselves for success; emphasising a clear understanding of your commercial journey and risk mitigation. - How DSV has created 54 companies through intentional, outcome-driven venture creation. Read the full interview here: https://lnkd.in/dcGq5Hfp

We just got named "Best BioTech-Focused Venture Capital Company 2025" by SME News 🚀 As part of the UK's Enterprise Awards, SME News based its selections solely on merit. The awards commend those most deserving for their ingenuity and hard work, distinguishing them from competitors and proving them worthy of recognition. For us, this award isn't just a title; it's a testament to the relentless dedication happening behind the scenes every single day. We're talking about nurturing ventures that are truly translating scientific breakthroughs into tangible impact, from curative therapeutics to revolutionary diagnostics. A huge thank you to everyone who believes in our mission: our brilliant scientists, dedicated founders, and supportive investors. And congratulations to all the winners. And a special shout-out to Kerstin Papenfuss, PhD MBA, and her incredible team for their awesome work making the world a healthier place! 🤭 Bonus fun fact: the failure rate of our biotech innovations is 6% over the last 5 years. Want to see the kind of impact we're creating? Learn more about our portfolio companies here: https://lnkd.in/d9mEFC4g

London Climate Action Week reminded us that serious climate action is alive and well, especially if you're in the business of building or backing real solutions. 🧠 We scoped high-impact areas for climate adaptation with Renaissance Philanthropy. 🔧 And celebrated startups actually deploying, not just promising, climate solutions. So, what exactly did we get up to? We kicked things off with a day hosted by our partners Renaissance Philanthropy, dedicated to discussing R&D translations for the climate emergencies with key stakeholders. William Summers proudly presented our scoping solutions, outlining ways in which we can unlock scalable, ethically grounded solutions that accelerate climate adaptation while aligning with long-term mitigation goals. You can learn more here - https://lnkd.in/dG88HXX8 Later in the week, we hosted an afternoon with HSBC Innovation Banking, bringing together investors, corporate innovation teams, and climate tech founders to showcase what effective corporate-startup collaboration looks like in practice, highlighting real-world pilots, live demonstrations, and early commercial traction. A massive shoutout to the teams who presented their groundbreaking work: Nicholas Chadwick, Mission Zero Technologies, Luke Tan, Supercritical, Alisha Fredriksson, Seabound, Harry Brooksbank, Nafura Advanced Technologies & Coca-Cola Europacific Partners, and Jack Hooper Rhizocore Technologies & Grosvenor.

Ready for Deep Tech? Deutschland hat die Brainpower – jetzt brauchen wir deinen Drive! Deep Tech is changing everything. Zeit, dass noch mehr kluge Köpfe aus Deutschland mit anpacken und vorne dabei sind. Bock auf Innovation, die wirklich einen Unterschied macht? Join us! Bewirb dich jetzt – bis zum 30. Juni ist noch Zeit! Bewirb dich noch heute 👉 https://lnkd.in/d7m6_uWR 🎥 Warum unser Programm genau dafür gemacht ist? Schau dir dieses kurze Testimonial von einer unserer aktuellen VSD Scholars Tori Wiederhöft, unterstützt durch SPRIND - Bundesagentur für Sprunginnovationen, an:

The incredible Kerstin Papenfuss, PhD MBA talking about how to create biotech companies from first principles, covering among other things: * our amazing partnerships with Cancer Research Horizons, Parkinson's UK, Cystic Fibrosis Foundation, Cell and Gene Therapy Catapult, Children's Tumor Foundation and General Inception * our portfolio companies in therapeutics such as Antiverse, Neobe Therapeutics, Plurify and Ancilia Biosciences * our process, applying an engineering mindset to science - starting with a desired therapeutic outcome (usually we want a cure!) and in doing so taking into account the factors required for a successful treatment such as delivery, scalability, manufacturability, cost of goods - from the very beginning...before even talking to academics - as opposed to jumping on a running train and trying to correct" 🚂

Massive congrats to DSV spinouts Kairos Carbon and Backwater (unannounced) for securing places in Milkywire Transformation Fund 2025!

Supercritical has just listed as one of the world’s top 150 Climate Startups to watch! This list was voted for by some of the world's top VCs. Thanks for the recognition, ClimateHack and HackSummit! It’s great to see our breakthrough technology and amazing team being recognised as we support industry think beyond fossil fuels! #supercritical #greenhydrogen